Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case

Hydroxycarbamide is used in the treatment of essential thrombocytosis and other myeloproliferative disorders. We report the case of a 63-year-old woman with essential thrombocytosis who had melanonychia after the long-term use of the hydroxycarbamide with a dose of 1000 mg/day. Two years after the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Malkan, Umit Yavuz, Gunes, Gursel, Eliacik, Eylem, Yayar, Okan, Haznedaroglu, Ibrahim Celalettin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537733/
https://www.ncbi.nlm.nih.gov/pubmed/26301108
http://dx.doi.org/10.1155/2015/653178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537733/
https://www.ncbi.nlm.nih.gov/pubmed/26301108
http://dx.doi.org/10.1155/2015/653178

Ejemplares similares